Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Vaccine. 2009 Dec 30;27 Suppl 6(Suppl 6):G21-6. doi: 10.1016/j.vaccine.2009.10.011.
In the last few years, a wealth of information has become available relating to the targets of vaccinia virus (VACV)-specific CD4(+) T cell, CD8(+) T cell and antibody responses. Due to the large size of its genome, encoding more than 200 different proteins, VACV represents a useful model system to study immunity to complex pathogens. Our data demonstrate that both cellular and humoral responses target a large number of antigens and epitopes. This broad spectrum of targets is detected in both mice and humans. CD4(+) T cell responses target late and structural antigens, while CD8(+) T cells preferentially recognize early antigens. While both CD4(+) and CD8(+) T cell responses target different types of antigens, the antigens recognized by T(H) cells are highly correlated with those recognized by antibody responses. We further show that protein abundance and antibody recognition can be used to predict antigens recognized by CD4(+) T cell responses, while early expression at the mRNA level predicts antigens targeted by CD8(+) T cells. Finally, we find that the vast majority of VACV epitopes are conserved in variola virus (VARV), thus suggesting that the epitopes defined herein also have relevance for the efficacy of VACV as a smallpox vaccine.
在过去的几年中,大量有关牛痘病毒(VACV)特异性 CD4(+) T 细胞、CD8(+) T 细胞和抗体反应的靶标信息已经变得可用。由于其基因组庞大,编码超过 200 种不同的蛋白质,VACV 代表了研究针对复杂病原体的免疫的有用模型系统。我们的数据表明,细胞和体液反应都针对大量的抗原和表位。在小鼠和人类中都检测到这种广泛的靶标。CD4(+) T 细胞反应针对晚期和结构抗原,而 CD8(+) T 细胞则优先识别早期抗原。虽然 CD4(+)和 CD8(+) T 细胞反应针对不同类型的抗原,但 T(H) 细胞识别的抗原与抗体反应识别的抗原高度相关。我们进一步表明,蛋白质丰度和抗体识别可用于预测 CD4(+) T 细胞反应识别的抗原,而 mRNA 水平的早期表达则预测 CD8(+) T 细胞靶向的抗原。最后,我们发现 VACV 中的绝大多数表位在天花病毒(VARV)中保守,因此表明本文中定义的表位也与 VACV 作为天花疫苗的功效相关。